MCAVOY DAVID R. (EVP, Chief Legal Officer) sold 28.8% of their position (4.83K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $76.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2025ACC: 0000950170-25-034670
Officer· EVP, Chief Legal Officer
Since Mar 2024
-4.83K
Net shares
Net seller
$76.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
16.74K acquired · 21.57K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+16.74K
Price / share
—
Trade value
—
% of position
New position
3/4/2025
0.00→16.74K
Ordinary Shares
Direct
Shares
−3.15K
Price / share
$15.73
Trade value
$49.56K
% of position
18.8%
3/4/2025
16.74K→13.59K
Ordinary Shares
Direct
Shares
−1.68K
Price / share
$15.91
Trade value
$26.69K
% of position
12.3%
3/5/2025
13.59K→11.91K
Total
Net shares
+11.91K
Net value
-$76.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/4/2025 | M · Option Exercise | +16.74K | — | — | New position | 0.00 | 16.74K |
| Ordinary Shares Direct | 3/4/2025 | S · Sale | −3.15K | $15.73 | $49.56K | 18.8% | 16.74K | 13.59K |
| Ordinary Shares Direct | 3/5/2025 | S · Sale | −1.68K | $15.91 | $26.69K | 12.3% | 13.59K | 11.91K |
| Total | +11.91K | -$76.25K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
16.74K shares
Shares
−16.74K
Strike price
Held after
50.22K
Exercisable
—
3/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares16.74K shares | 3/4/2025 | M · Option Exercise | −16.74K | — | 50.22K |